Publications by authors named "Patrick Cobb"

Claim this Profile
M
Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results.
Ecaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder, Gregory M Cote, Glenn J Hanna, Patrick Cobb

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Carlo Palmieri, Hannah Linden, Stephen N Birrell, Sally Wheelwright, Elgene Lim, Patrick Cobb

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Marc S Hoffmann, Bradley D Hunter, Patrick W Cobb, Juan C Varela, Javier Munoz

Transplant Cell Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early detection on cancer curability: A modified Delphi panel study.
Lee Schwartzberg, Michael S Broder, Sikander Ailawadhi, Himisha Beltran, L Johnetta Blakely, Patrick Cobb

PLoS One· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar.
Patrick Cobb, Dietger Niederwieser, Stanley Cohen, Caroline Hamm, Gerd Burmester

Immunotherapy· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth

Target Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth

Target Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study.
Patrick Wayne Cobb, Yong Wha Moon, Klára Mezei, István Láng, Gajanan Bhat

Cancer Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
Lee S Schwartzberg, Gajanan Bhat, Julio Peguero, Richy Agajanian, Jayaram S Bharadwaj, Patrick Wayne Cobb

Oncologist· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura.
Hiral D Parekh, Jessica A Reese, Patrick W Cobb, James N George

Am J Hematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma.
Jeannine M Brant, Susan L Beck, William N Dudley, Patrick Cobb, Ginette Pepper

Eur J Oncol Nurs· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom trajectories in posttreatment cancer survivors.
Jeannine M Brant, Susan Beck, William N Dudley, Patrick Cobb, Ginette Pepper

Cancer Nurs· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer.
Lee S Schwartzberg, Patrick Cobb, Mark S Walker, Edward J Stepanski, Arthur C Houts

Support Care Cancer· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
Lee S Schwartzberg, Patrick Cobb, Frank Senecal, David Henry, Kimary Kulig

Breast· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.
James H Doroshow, Sheryl McCoy, John S Macdonald, Brian F Issell, Taral Patel, Patrick W Cobb

Invest New Drugs· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis